FDA expands monkeypox vaccine authorization to increase vaccine supply.
Intradermal injection - this will significantly increase the available supply of vaccines, up to 5 fold. Also, those high-risk under 18 years of age also eligible.
In some big news today regarding monkeypox, the FDA expanded the authorization for monkeypox vaccine Jynneos to allow healthcare workers to administer it via the intradermal route (into the skin), instead of the usual subcutaneous way (a full dose deeper into the fat) The FDA also shared that studies had shown that the vaccine was just as effective when administered intradermally as it was subcutaneously.
Monkeypox spreads

The monkeypox outbreak continues to spread in the United States, with the US logging almost 9,500 monkeypox cases (likely many more that are undiagnosed), with an acute shortage of available vaccine doses. If you remember, the Biden administration last week declared monkeypox a public health emergency (better late than never!)
The FDA announcement today is significant because it allows us to use much lower doses of vaccine than we would for the usual subcutaneous administration (injecting into the deeper fat) - the hope is that it will allows us to vaccine 5 times more people than we could previously!
Furthermore, this new authorization has also expanded eligibility of the vaccine to people younger than 18 who are at high risk of infection. This means high risk children can get vaccinated!
Eligibility still limited to those at high-risk for infection
The vaccine remains limited to those who are at high-risk of infection, even with the above changes. I think at that time this makes sense, especially as supplies are extremely limited.
What next?
The monkeypox outbreak in the US is concerning, and a rapidly developing story - but at this time there is no reason to panic. We can all take precautions to reduce our risk of infection: avoid crowded spaces, wearing masks in public, and reporting any suspicious rashes to your doctor immediately. The CDC also has specific guidance on reducing the risk of spread via sexual activity.
Stay tuned for more developments as they happen, and thanks for reading!
Questions? Leave a comment on this post, or email me at drsiyabmd@gmail.com!
Follow Dr. Siyab on TikTok, Instagram, and Twitter
I work hard on providing the most up-to-date and evidence based information regarding COVID-19, monkeypox and other medical and health issues, on social media and this newsletter, for free. If you have benefited from it, please consider making a small donation to support my mission: Venmo or PayPal. Thank you for your support!
Monkey pox is spreading because of mRNA vaccine induced immunocompromise. The monkey pox vaccine will fail due to immunocompromise. This is just the latest medical fraud.